Literature DB >> 27206840

Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration.

Usha Chakravarthy1, Dafna Goldenberg2, Graham Young3, Moshe Havilio4, Omer Rafaeli4, Gidi Benyamini4, Anat Loewenstein2.   

Abstract

PURPOSE: The objective of the study was to evaluate the accuracy of the Notal OCT Analyzer (NOA) versus that of a retina specialist (RS) in the automated detection of fluid on optical coherence tomography (OCT).
DESIGN: A study of the performance of the NOA compared with the results from 3 RSs. PARTICIPANTS: A selection of 155 anonymized OCT scans (Zeiss Cirrus; Carl Zeiss Meditec, Dublin, CA) from an image repository at a single tertiary referral retina center (Belfast Health and Social Care Trust, Belfast, United Kingdom) after approval from the local data guardian of the clinical site.
METHODS: One hundred fifty-five OCT cube scans were stripped of all clinical identifiers and exported. The NOA and 3 independent RSs analyzed all 128 B-scans of each cube scan for the presence of intraretinal fluid, subretinal fluid, and sub-retinal pigment epithelium fluid. The NOA also ranked individual B-scans of each volume scan for likelihood of CNV activity, which was subjected to a second grading session by the 3 RSs. MAIN OUTCOME MEASURES: The NOA's sensitivity and specificity versus the RS grading and the NOA's performance in ranking B-scans for activity.
RESULTS: One hundred forty-two cube scans met the inclusion criteria for the primary analysis. On testing the RS grading versus the NOA, the accuracy was 91% (95% confidence interval [CI], ±7%), sensitivity was 92% (95% CI, ±6%), and specificity was 91% (95% CI, ±6%), meeting the primary outcome. The graders' accuracy when compared with the majority of the other graders (including a fourth grader) was 93%. On average, the 3 graders could identify fluid in 95% of scans by just reviewing a single cross-section with the highest NOA score and 99.5% of scans with fluid by viewing the top 3 cross-sections.
CONCLUSIONS: Concordance between the NOA and the RS determination of lesion activity was extremely high. The level of discrepancy between the RS and the NOA results was similar to the NOA's mismatches. Our results show that automated delineation of the retinal contours combined with interpretation of disease activity is feasible and has the potential to become a powerful tool in terms of its clinical applications.
Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27206840     DOI: 10.1016/j.ophtha.2016.04.005

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  20 in total

1.  Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.

Authors:  Justis P Ehlers; Atsuro Uchida; Ming Hu; Natalia Figueiredo; Peter K Kaiser; Jeffrey S Heier; David M Brown; David S Boyer; Diana V Do; Andrea Gibson; Namrata Saroj; Sunil K Srivastava
Journal:  Ophthalmol Retina       Date:  2019-07-06

Review 2.  [Potential of methods of artificial intelligence for quality assurance].

Authors:  Philipp Berens; Sebastian M Waldstein; Murat Seckin Ayhan; Louis Kümmerle; Hansjürgen Agostini; Andreas Stahl; Focke Ziemssen
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

3.  Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD.

Authors:  Claus von der Burchard; Felix Treumer; Christoph Ehlken; Stefan Koinzer; Konstantine Purtskhvanidze; Jan Tode; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-18       Impact factor: 3.117

4.  Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.

Authors:  Antonio Yaghy; Aaron Y Lee; Pearse A Keane; Tiarnan D L Keenan; Luisa S M Mendonca; Cecilia S Lee; Anne Marie Cairns; Joseph Carroll; Hao Chen; Julie Clark; Catherine A Cukras; Luis de Sisternes; Amitha Domalpally; Mary K Durbin; Kerry E Goetz; Felix Grassmann; Jonathan L Haines; Naoto Honda; Zhihong Jewel Hu; Christopher Mody; Luz D Orozco; Cynthia Owsley; Stephen Poor; Charles Reisman; Ramiro Ribeiro; Srinivas R Sadda; Sobha Sivaprasad; Giovanni Staurenghi; Daniel Sw Ting; Santa J Tumminia; Luca Zalunardo; Nadia K Waheed
Journal:  Exp Eye Res       Date:  2022-05-04       Impact factor: 3.770

5.  Study the past if you would define the future (Confucius).

Authors:  Tiarnan D Keenan; Emily Y Chew
Journal:  Br J Ophthalmol       Date:  2020-02-14       Impact factor: 4.638

6.  Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.

Authors:  Tiarnan D L Keenan; Usha Chakravarthy; Anat Loewenstein; Emily Y Chew; Ursula Schmidt-Erfurth
Journal:  Am J Ophthalmol       Date:  2021-02-15       Impact factor: 5.258

7.  Computer-aided detection and abnormality score for the outer retinal layer in optical coherence tomography.

Authors:  Tyler Hyungtaek Rim; Aaron Yuntai Lee; Daniel S Ting; Kelvin Yi Chong Teo; Hee Seung Yang; Hyeonmin Kim; Geunyoung Lee; Zhen Ling Teo; Alvin Teo Wei Jun; Kengo Takahashi; Tea Keun Yoo; Sung Eun Kim; Yasuo Yanagi; Ching-Yu Cheng; Sung Soo Kim; Tien Yin Wong; Chui Ming Gemmy Cheung
Journal:  Br J Ophthalmol       Date:  2021-04-19       Impact factor: 5.908

8.  Evaluating the impact of vitreomacular adhesion on anti-VEGF therapy for retinal vein occlusion using machine learning.

Authors:  Sebastian M Waldstein; Alessio Montuoro; Dominika Podkowinski; Ana-Maria Philip; Bianca S Gerendas; Hrvoje Bogunovic; Ursula Schmidt-Erfurth
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

9.  Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring.

Authors:  Peter Maloca; Pascal W Hasler; Daniel Barthelmes; Patrik Arnold; Mooser Matthias; Hendrik P N Scholl; Heinrich Gerding; Justus Garweg; Tjebo Heeren; Konstantinos Balaskas; J Emanuel Ramos de Carvalho; Catherine Egan; Adnan Tufail; Sandrine A Zweifel
Journal:  Transl Vis Sci Technol       Date:  2018-07-24       Impact factor: 3.283

10.  Artificial Intelligence: Quo Vadis?

Authors:  Marco A Zarbin
Journal:  Transl Vis Sci Technol       Date:  2020-01-29       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.